Metformin Accord

Metformin Hydrochloride, the active ingredient in Metformin Accord, is a Biguanide presented as an oral dosage form for oral use. It is used to lower blood glucose in adults with type 2 diabetes mellitus, helping improve insulin sensitivity and reduce hepatic glucose output, which contributes to better glycemic control.

GNH USA supplies Metformin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Metformin Accord, a Biguanide antidiabetic agent, is employed in the management of disorders related to impaired glucose regulation.

- Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Impaired glucose tolerance: helps delay progression to overt diabetes. - Polycystic ovary syndrome: assists in restoring ovulatory cycles and reducing insulin resistance.

Metformin Accord may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset often occurring at treatment initiation. - Diarrhea: frequent loose stools, usually transient. - Abdominal discomfort: cramping or pain in the abdomen. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: marked elevation of liver enzymes or liver failure.

When prescribing Metformin Accord, clinicians should consider several safety precautions to minimize risk. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic disease: avoid use in patients with severe liver impairment. - Alcohol consumption: limit intake as it may increase risk of lactic acidosis. - Pregnancy: discuss potential risks and benefits with the prescriber. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Accord can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise plasma metformin concentrations. - Alcohol: synergistic effect on lactate accumulation.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: require monitoring of renal function and electrolytes.